An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Nanomix to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and Hosted by M-Vest
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Nanomix Corporation (OTC-PINK: NNMXD, NNMX) will participate in the 2022 Virtual Growth Conference hosted by Maxim Group LLC from March 28-30, 2022. CEO David Ludvigson will present a company overview during the event. A pre-recorded presentation will be accessible for 72 hours from March 28, 9:00 a.m. ET, and an archived replay will be available on Nanomix's investor relations website.
Positive
None.
Negative
None.
EMERYVILLE, Calif.--(BUSINESS WIRE)--
Nanomix Corporation (OTCBB: NNMX, NNMXD), a leader in the development of mobile, affordable, point-of-care diagnostics, today announced that David Ludvigson, President and Chief Executive Officer, will participate in the 2022 Virtual Growth Conference, presented by Maxim Group LLC and hosted by M-Vest, being held virtually March 28-30, 2022.
A pre-recorded company presentation will be available to conference attendees for 72 hours beginning March 28 at 9:00 a.m. Eastern time and can be accessed here. An archived replay of the webcast will also be available on Nanomix’s investor relations website. Interested investors may register for the conference to access the webcast at https://m-vest.com/events/2022-virtual-growth-conference.
During this virtual conference, investors will hear from executives from a wide range of sectors including Biotech, Clean Energy, Electric Vehicles, Financial Services, Fintech & REITS, Gaming & Entertainment, Healthcare, Healthcare IT, Infrastructure, Shipping and Technology/ Media/Telecom. The conference will feature company presentations, fireside chats, roundtable discussions and live Q&A with CEOs moderated by Maxim Research Analysts.
About Nanomix Corporation
Nanomix is the leader in the development of mobile point-of-care diagnostics with its Nanomix eLab platform and assays that provide rapid, accurate, quantitative information for use in settings where time is critical to clinical decision-making and improved patient care. The company’s products are designed to broadly impact healthcare delivery by bringing diagnostics to the point of initial patient interaction, whether in the hospital or in pre-hospital, remote or alternate-care settings, with the goal to enable faster clinical decision-making and potentially treatment-in-place. Nanomix’s first assay addresses the critical need for faster diagnosis of critical infections. The company is developing a pipeline of other tests designed to improve patient outcomes by making high-quality diagnostic information available within minutes. For more information, visit www.nano.com.
